# PYLERA

NDC: 61269-381
Generic name: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE
Labeler / Manufacturer: H2-Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250818

FDA application: NDA050786

## Active ingredients

- BISMUTH SUBCITRATE POTASSIUM: 140 mg/1
- METRONIDAZOLE: 125 mg/1
- TETRACYCLINE HYDROCHLORIDE: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61269-381"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61269-381
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c50626a2-5969-490b-a88a-a4ee45e79615